pharmaphorum

OCTOBER 3, 2022

Amylyx Pharmaceuticals’ Relyvrio – a new treatment for amyotrophic lateral sclerosis (ALS) approved by the FDA on Thursday, after review of the data from its phase 2 trial – was the next day set at a list price of $158,000 per year in the US, sparking outcry. ALS affects over 30,000 people in the US.

Drug Pricing 52

Drug Pricing 52

PharmaShots

FEBRUARY 17, 2023

Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy Date: Feb 17, 2023 | Tags: Iveric Bio, Avacincaptad Pegol, Geographic Atrophy, Regulatory, US, FDA, NDA, Priority Review ALX Oncology Reports the First Patient Dosing of Evorpacept in the P-I Study (ASPEN-07) for the Treatment of (..)

Biosimilars 40

Biosimilars Vaccines 40

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Communication 52

Communication 52

European Pharmaceutical Review

MAY 22, 2023

Smart contracts, which are essential for easing international trade and logistics operations, can enable the user to track fake returns to the producer and supplier using RFID tags. In conclusion, Kordestani et al. Blockchain offers the possibility of non-modifiable data uploading with traceability and low-cost data storage.

90

90

FDA Law Blog: Biosimilars

JUNE 27, 2023

Duchenne, Friederichs’s Ataxia, Sickle Cell Disease, Chagas, ALS). In addition to Mr. Karst, ten other HP&M Directors were tagged as “Recommended” by WWL: Life Sciences 2023: Ricardo Carvajal Robert A. Dormer Jeffrey N. Gibbs Paul M. Hyman Alan M. Kirschenbaum Allyson B. Mullen Frank J. Sasinowski Jeffrey K.

Drug Development 81

Drug Development Pharmaceutical Manufacturing 81

European Pharmaceutical Review

AUGUST 24, 2022

tag ® , inspired by the unique features of microtubule biology and perfectly suited for DAR 2 and DAR 4 ADCs. Fu Z, Li S, Han S, et al. Zacharias N, Podust V, Kajihara K, et al. Modi S, Saura C, Yamashita T, et al. Kasper M, Lassak L, Vogl A, et al. Schumacher D, Helma J, Mann F, et al. 2021;18(6):327-344.

Compounding 82

Compounding Pharmaceutical Companies Pharmaceutical Companies 82

European Pharmaceutical Review

DECEMBER 27, 2023

This is in addition to its considerable price tag. Grupp SA, Kalos M, Barrett D, et al. Mirza A-S, Hosing C, Foss FM, et al. Zhang H, Liu M, Li Q, et al. Asghar N, et al. Rejeski K, Perez A, Sesques P, et al. Schultz LM, Baggott C, Prabhu S, et al. Hayden PJ et al. Cytotherapy.

Adverse Reactions 82

Adverse Reactions Immunity Immunization Medical Schools 82